Skip to main content
Erschienen in: Endocrine 2/2018

22.05.2017 | Original Article

MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors

verfasst von: Letizia Vannucci, Francesca Marini, Francesca Giusti, Simone Ciuffi, Francesco Tonelli, Maria Luisa Brandi

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively evaluate the age of onset of MEN1-associated lesions in a group of affected children and adolescents and to compare the clinical features of our series with the evidence derived from the literature.

Methods

The study population consisted of 22 Italian children and adolescents (age 6–31 years at the time of the inclusion in this study) all with a clinical and/or a genetic diagnosis of MEN1 performed before the age of 16 who have been followed-up regularly from 1998 to 2016 at the Regional Referral Center for Hereditary Endocrine Tumors. Clinical, biochemical, imaging and genetic data have been collected for each patient.

Results

Ten subjects (45.5%) have not yet presented any clinical/biochemical/radiological manifestation of MEN1 disease, whereas 12 patients (54.5%) developed at least one MEN1-associated endocrine manifestation. The second group of patients was significantly older than the first one. The most frequent manifestation was primary hyperparathyroidism (50%), followed by pituitary tumors (prolactinomas) (31.8%) and nonfunctioning pancreatic neuroendocrine tumors (9%). The earliest cases of primary hyperparathyroidism and prolactinoma were a 12-year-old girl and a 13-year-old boy, respectively.

Conclusions

MEN1 disease seems to present with different features in children and adolescents from those in adults. Our study confirms the fundamental importance of screening for tumors in young MEN1 patients beginning in early childhood, in order to avoid diagnostic and therapeutic delays.
Literatur
1.
Zurück zum Zitat A. Falchetti, F. Marini, F. Tonelli, M.L. Brandi, Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. Ann. Endocrinol. 66, 195–205 (2005)CrossRef A. Falchetti, F. Marini, F. Tonelli, M.L. Brandi, Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. Ann. Endocrinol. 66, 195–205 (2005)CrossRef
2.
Zurück zum Zitat R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi, Endocrine Society: Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990–3011 (2012)CrossRefPubMed R.V. Thakker, P.J. Newey, G.V. Walls, J. Bilezikian, H. Dralle, P.R. Ebeling, S. Melmed, A. Sakurai, F. Tonelli, M.L. Brandi, Endocrine Society: Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990–3011 (2012)CrossRefPubMed
3.
Zurück zum Zitat P. Goudet, A. Dalac, M. Le Bras, C. Cardot-Bauters, P. Niccoli, N. Lévy-Bohbot, H. du Boullay, X. Bertagna, P. Ruszniewski, F. Borson-Chazot, B. Vergès, J.L. Sadoul, F. Ménégaux, A. Tabarin, J.M. Kühn, P. d’Anella, O. Chabre, S. Christin-Maitre, G. Cadiot, C. Binquet, B. Delemer, MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d’étude des tumeurs endocrines. J. Clin. Endocrinol. Metab. 100, 1568–1577 (2015)CrossRefPubMed P. Goudet, A. Dalac, M. Le Bras, C. Cardot-Bauters, P. Niccoli, N. Lévy-Bohbot, H. du Boullay, X. Bertagna, P. Ruszniewski, F. Borson-Chazot, B. Vergès, J.L. Sadoul, F. Ménégaux, A. Tabarin, J.M. Kühn, P. d’Anella, O. Chabre, S. Christin-Maitre, G. Cadiot, C. Binquet, B. Delemer, MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d’étude des tumeurs endocrines. J. Clin. Endocrinol. Metab. 100, 1568–1577 (2015)CrossRefPubMed
4.
Zurück zum Zitat C. Marcocci, M.L. Brandi, A. Scillitani, S. Corbetta, A. Faggiano, L. Gianotti, S. Migliaccio, S. Minisola, Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J. Endocrinol. Invest. 38, 577–593 (2015)CrossRefPubMed C. Marcocci, M.L. Brandi, A. Scillitani, S. Corbetta, A. Faggiano, L. Gianotti, S. Migliaccio, S. Minisola, Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J. Endocrinol. Invest. 38, 577–593 (2015)CrossRefPubMed
5.
Zurück zum Zitat N. Mitre, K. Mack, D. Babovic-Vuksanovic, G. Thompson, S. Kumar, Ischemic stroke as the presenting symptom of primary hyperparathyroidism due to multiple endocrine neoplasia type 1. J. Pediatr. 153, 582–585 (2008)CrossRefPubMed N. Mitre, K. Mack, D. Babovic-Vuksanovic, G. Thompson, S. Kumar, Ischemic stroke as the presenting symptom of primary hyperparathyroidism due to multiple endocrine neoplasia type 1. J. Pediatr. 153, 582–585 (2008)CrossRefPubMed
6.
Zurück zum Zitat C.A. Stratakis, D.H. Schussheim, S.M. Freedman, M.F. Keil, S.D. Pack, S.K. Agarwal, M.C. Skarulis, R.J. Weil, I.A. Lubensky, Z. Zhuang, E.H. Oldfield, S.J. Marx, Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 85, 4776–4780 (2000)PubMed C.A. Stratakis, D.H. Schussheim, S.M. Freedman, M.F. Keil, S.D. Pack, S.K. Agarwal, M.C. Skarulis, R.J. Weil, I.A. Lubensky, Z. Zhuang, E.H. Oldfield, S.J. Marx, Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 85, 4776–4780 (2000)PubMed
7.
Zurück zum Zitat Gan, H.W., Bulwer, C., Jeelani, O., Levine, M.A., Korbonits, M., Spoudeas, H.A: Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1. Int. J. Pediatr. Endocrinol.2015, 15 (2015) Gan, H.W., Bulwer, C., Jeelani, O., Levine, M.A., Korbonits, M., Spoudeas, H.A: Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1. Int. J. Pediatr. Endocrinol.2015, 15 (2015)
8.
Zurück zum Zitat G. Kontogeorgos, N. Kapranos, I. Tzavara, N. Thalassinos, D. Rologis, Monosomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1. Clin. Endocrinol. (Oxf) 54, 117–120 (2001)CrossRef G. Kontogeorgos, N. Kapranos, I. Tzavara, N. Thalassinos, D. Rologis, Monosomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1. Clin. Endocrinol. (Oxf) 54, 117–120 (2001)CrossRef
9.
Zurück zum Zitat W.F. Simonds, S. Varghese, S.J. Marx, L.K. Nieman, Cushing’s syndrome in multiple endocrine neoplasia type 1. Clin. Endocrinol. (Oxf) 76, 379–386 (2012)CrossRef W.F. Simonds, S. Varghese, S.J. Marx, L.K. Nieman, Cushing’s syndrome in multiple endocrine neoplasia type 1. Clin. Endocrinol. (Oxf) 76, 379–386 (2012)CrossRef
10.
Zurück zum Zitat C. Nozières, P. Berlier, C. Dupuis, C. Raynaud-Ravni, Y. Morel, F.B. Chazot, M. Nicolino, Sporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature. Orphanet J. Rare Dis. 6, 67 (2011)CrossRefPubMedPubMedCentral C. Nozières, P. Berlier, C. Dupuis, C. Raynaud-Ravni, Y. Morel, F.B. Chazot, M. Nicolino, Sporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature. Orphanet J. Rare Dis. 6, 67 (2011)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat M. Rix, N.T. Hertel, F.C. Nielsen, B.B. Jacobsen, A.S. Hoejberg, K. Brixen, J. Hangaard, J.P. Kroustrup, Cushing’s disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur. J. Endocrinol. 151, 709–715 (2004)CrossRefPubMed M. Rix, N.T. Hertel, F.C. Nielsen, B.B. Jacobsen, A.S. Hoejberg, K. Brixen, J. Hangaard, J.P. Kroustrup, Cushing’s disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur. J. Endocrinol. 151, 709–715 (2004)CrossRefPubMed
12.
Zurück zum Zitat P.J. Newey, J. Jeyabalan, G.V. Walls, P.T. Christie, F.V. Gleeson, S. Gould, P.R. Johnson, R.R. Phillips, F.J. Ryan, B. Shine, M.R. Bowl, R.V. Thakker, Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbour nonfunctioning pancreatic neuroendocrine tumors. J. Clin. Endocrinol. Metab. 94, 3640–3646 (2009)CrossRefPubMed P.J. Newey, J. Jeyabalan, G.V. Walls, P.T. Christie, F.V. Gleeson, S. Gould, P.R. Johnson, R.R. Phillips, F.J. Ryan, B. Shine, M.R. Bowl, R.V. Thakker, Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbour nonfunctioning pancreatic neuroendocrine tumors. J. Clin. Endocrinol. Metab. 94, 3640–3646 (2009)CrossRefPubMed
13.
Zurück zum Zitat B.W. Scheithauer, K. Kovacs, V. Nose, M. Lombardero, Y.R. Osamura, R.V. Lloyd, E. Horvath, A. Pagenstecher, J.E. Bohl, D.S. Tews, Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example. Hum. Pathol. 40, 270–278 (2009)CrossRefPubMed B.W. Scheithauer, K. Kovacs, V. Nose, M. Lombardero, Y.R. Osamura, R.V. Lloyd, E. Horvath, A. Pagenstecher, J.E. Bohl, D.S. Tews, Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example. Hum. Pathol. 40, 270–278 (2009)CrossRefPubMed
14.
Zurück zum Zitat T. Cuny, M. Pertuit, M. Sahnoun-Fathallah, A. Daly, G. Occhi, M.F. Odou, A. Tabarin, M.L. Nunes, B. Delemer, V. Rohmer, R. Desailloud, V. Kerlan, O. Chabre, J.L. Sadoul, M. Cogne, P. Caron, C. Cortet-Rudelli, A. Lienhardt, I. Raingeard, A.M. Guedj, T. Brue, A. Beckers, G. Weryha, A. Enjalbert, A. Barlier, Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don’t forget MEN1 genetic analysis. Eur. J. Endocrinol. 168, 533–541 (2013)CrossRefPubMed T. Cuny, M. Pertuit, M. Sahnoun-Fathallah, A. Daly, G. Occhi, M.F. Odou, A. Tabarin, M.L. Nunes, B. Delemer, V. Rohmer, R. Desailloud, V. Kerlan, O. Chabre, J.L. Sadoul, M. Cogne, P. Caron, C. Cortet-Rudelli, A. Lienhardt, I. Raingeard, A.M. Guedj, T. Brue, A. Beckers, G. Weryha, A. Enjalbert, A. Barlier, Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don’t forget MEN1 genetic analysis. Eur. J. Endocrinol. 168, 533–541 (2013)CrossRefPubMed
15.
Zurück zum Zitat T.D. Gonçalves, R.A. Toledo, T. Sekiya, S.E. Matuguma, F. Maluf Filho, M.S. Rocha, S.A. Siqueira, A. Glezer, M.D. Bronstein, M.A. Pereira, R. Jureidini, T. Bacchella, M.C. Machado, S.P. Toledo, D.M. Lourenço Jr, Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. J. Clin. Endocrinol. Metab. 99, E89–96 (2014)CrossRefPubMed T.D. Gonçalves, R.A. Toledo, T. Sekiya, S.E. Matuguma, F. Maluf Filho, M.S. Rocha, S.A. Siqueira, A. Glezer, M.D. Bronstein, M.A. Pereira, R. Jureidini, T. Bacchella, M.C. Machado, S.P. Toledo, D.M. Lourenço Jr, Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life. J. Clin. Endocrinol. Metab. 99, E89–96 (2014)CrossRefPubMed
16.
Zurück zum Zitat A. Sakurai, M. Yamazaki, S. Suzuki, T. Fukushima, T. Imai, T. Kikumori, T. Okamoto, K. Horiuchi, S. Uchino, S. Kosugi, M. Yamada, I. Komoto, K. Hanazaki, M. Itoh, T. Kondo, M. Mihara, M. Imamura, Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr. J. 59, 859–866 (2012)CrossRefPubMed A. Sakurai, M. Yamazaki, S. Suzuki, T. Fukushima, T. Imai, T. Kikumori, T. Okamoto, K. Horiuchi, S. Uchino, S. Kosugi, M. Yamada, I. Komoto, K. Hanazaki, M. Itoh, T. Kondo, M. Mihara, M. Imamura, Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan. Endocr. J. 59, 859–866 (2012)CrossRefPubMed
17.
Zurück zum Zitat H.C. Fabbri, M.P. Mello, F.C. Soardi, A.M. Esquiaveto-Aun, D.M. Oliveira, F.C. Denardi, A. Moura-Neto, H.M. Garmes, M.T. Baptista, P.S. Matos, S.H. Lemos-Marini, L.F. D’Souza-Li, G. Guerra-Júnior, Long-term follow-up of an 8-year-old boy with insulinoma as the first manifestation of a familial form of multiple endocrine neoplasia type 1. Arq. Bras. Endocrinol. Metabol. 54, 754–760 (2010)CrossRefPubMed H.C. Fabbri, M.P. Mello, F.C. Soardi, A.M. Esquiaveto-Aun, D.M. Oliveira, F.C. Denardi, A. Moura-Neto, H.M. Garmes, M.T. Baptista, P.S. Matos, S.H. Lemos-Marini, L.F. D’Souza-Li, G. Guerra-Júnior, Long-term follow-up of an 8-year-old boy with insulinoma as the first manifestation of a familial form of multiple endocrine neoplasia type 1. Arq. Bras. Endocrinol. Metabol. 54, 754–760 (2010)CrossRefPubMed
18.
Zurück zum Zitat E.B. Kwon, H.R. Jeong, Y.S. Shim, H.S. Lee, J.S. Hwang, Multiple endocrine neoplasia type 1 presenting as hypoglycemia due to insulinoma. J. Korean Med. Sci. 31, 1003–1006 (2016)CrossRefPubMedPubMedCentral E.B. Kwon, H.R. Jeong, Y.S. Shim, H.S. Lee, J.S. Hwang, Multiple endocrine neoplasia type 1 presenting as hypoglycemia due to insulinoma. J. Korean Med. Sci. 31, 1003–1006 (2016)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat R.T. Jensen, M.J. Berna, D.B. Bingham, J.A. Norton, Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113, 1807–1843 (2008)CrossRefPubMedPubMedCentral R.T. Jensen, M.J. Berna, D.B. Bingham, J.A. Norton, Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 113, 1807–1843 (2008)CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat P. Goudet, A. Murat, C. Cardot-Bauters, P. Emy, E. Baudin, H. du Boullay Choplin, Y. Chapuis, J.L. Kraimps, J.L. Sadoul, A. Tabarin, B. Vergès, B. Carnaille, P. Niccoli-Sire, A. Costa, A. Calender, GTE network (Groupe des Tumeurs Endocrines): Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des tumeurs endocrines). World J. Surg. 33, 1197–1207 (2009)CrossRefPubMed P. Goudet, A. Murat, C. Cardot-Bauters, P. Emy, E. Baudin, H. du Boullay Choplin, Y. Chapuis, J.L. Kraimps, J.L. Sadoul, A. Tabarin, B. Vergès, B. Carnaille, P. Niccoli-Sire, A. Costa, A. Calender, GTE network (Groupe des Tumeurs Endocrines): Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des tumeurs endocrines). World J. Surg. 33, 1197–1207 (2009)CrossRefPubMed
Metadaten
Titel
MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors
verfasst von
Letizia Vannucci
Francesca Marini
Francesca Giusti
Simone Ciuffi
Francesco Tonelli
Maria Luisa Brandi
Publikationsdatum
22.05.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1322-5

Weitere Artikel der Ausgabe 2/2018

Endocrine 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.